Kayne Anderson Rudnick Investment Management LLC Sanofi Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Sanofi stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 13,367 shares of SNY stock, worth $641,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,367

Previous 16,648 19.71%

Holding current value

$641,214

Previous $807,000 4.58%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$48.54 - $58.53 $159,259 - $192,036	-3,281 Reduced 19.71%	13,367 $770,000
Q2 2024 Aug 13, 2024	SELL	$45.39 - $50.36 $22,150 - $24,575	-488 Reduced 2.85%	16,648 $807,000
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $216,077 - $247,863	-4,723 Reduced 21.61%	17,136 $832,000
Q4 2023 Feb 13, 2024	SELL	$43.13 - $54.79 $16,346 - $20,765	-379 Reduced 1.7%	21,859 $1.09 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $181,432 - $196,567	-3,561 Reduced 13.8%	22,238 $1.19 Million
Q2 2023 Aug 11, 2023	SELL	$50.45 - $57.18 $447,642 - $507,358	-8,873 Reduced 25.59%	25,799 $1.39 Million
Q1 2023 May 16, 2023	SELL	$45.86 - $54.45 $25,544 - $30,328	-557 Reduced 1.58%	34,672 $1.89 Million
Q4 2022 Feb 13, 2023	BUY	$38.86 - $48.55 $166,631 - $208,182	4,288 Added 13.86%	35,229 $1.71 Million
Q3 2022 Nov 16, 2022	BUY	$37.22 - $100.5 $1.15 Million - $3.11 Million	30,941 New	30,941 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $1.28 Million - $3.44 Million	-34,264 Closed	0 $1.18 Million
Q2 2022 Aug 12, 2022	BUY	$48.99 - $57.46 $489 - $574	10 Added 0.03%	34,264 $1.71 Million
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $37,911 - $41,954	-782 Reduced 2.23%	34,254 $1.76 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $19,722 - $21,934	-419 Reduced 1.18%	35,036 $1.76 Million
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $50,332 - $55,829	1,051 Added 3.05%	35,455 $1.71 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $9,822 - $10,795	-199 Reduced 0.58%	34,404 $1.81 Million
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $92,374 - $102,636	2,032 Added 6.24%	34,603 $1.71 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $129,693 - $147,788	2,863 Added 9.64%	32,571 $1.58 Million
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $88,007 - $95,656	-1,779 Reduced 5.65%	29,708 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$42.91 - $52.5 $499,000 - $610,522	-11,629 Reduced 26.97%	31,487 $1.61 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $49,007 - $66,589	-1,289 Reduced 2.9%	43,116 $1.89 Million
Q4 2019 Feb 13, 2020	SELL	$44.25 - $50.86 $5,398 - $6,204	-122 Reduced 0.27%	44,405 $2.23 Million
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $98,066 - $113,381	2,431 Added 5.77%	44,527 $2.06 Million
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $78,919 - $86,473	-1,952 Reduced 4.43%	42,096 $1.82 Million
Q1 2019 Jun 12, 2019	SELL	$40.83 - $45.43 $16,944 - $18,853	-415 Reduced 0.93%	44,048 $1.95 Million
Q1 2019 May 10, 2019	SELL	$40.83 - $45.43 $248,083 - $276,032	-6,076 Reduced 12.02%	44,463 $1.97 Million
Q4 2018 Feb 06, 2019	SELL	$41.48 - $45.59 $541,770 - $595,450	-13,061 Reduced 20.54%	50,539 $2.19 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $1,360 - $1,524	-34 Reduced 0.05%	63,600 $2.84 Million
Q2 2018 Aug 13, 2018	SELL	$37.63 - $41.22 $133,511 - $146,248	-3,548 Reduced 5.28%	63,634 $2.55 Million
Q1 2018 May 09, 2018	BUY	$38.98 - $45.76 $548,058 - $643,385	14,060 Added 26.47%	67,182 $2.69 Million
Q4 2017 Feb 12, 2018	BUY	$42.86 - $50.61 $64,547 - $76,218	1,506 Added 2.92%	53,122 $2.28 Million
Q3 2017 Nov 07, 2017	BUY	$47.04 - $50.34 $2.43 Million - $2.6 Million	51,616	51,616 $2.57 Million

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account

Kayne Anderson Rudnick Investment Management LLC Sanofi Transaction History